134 related articles for article (PubMed ID: 12469798)
21. Effect of re-feeding after starvation on biomechanical properties in rat small intestine.
Dou Y; Gregersen S; Zhao J; Zhuang F; Gregersen H
Med Eng Phys; 2001 Oct; 23(8):557-66. PubMed ID: 11719078
[TBL] [Abstract][Full Text] [Related]
22. Effect of gliclazide on the functional response to calcium in diabetic rat heart.
Shinzato T; Shimabukuro M; Higa S; Nagamine F; Murakami K; Takasu N
Gen Pharmacol; 1996 Apr; 27(3):471-5. PubMed ID: 8723529
[TBL] [Abstract][Full Text] [Related]
23. Prevention of endothelial dysfunction in streptozotocin-induced diabetic rats by gliclazide treatment.
Vallejo S; Angulo J; Peiró C; Sánchez-Ferrer A; Cercas E; Llergo JL; Nevado J; Sánchez-Ferrer CF; Rodríguez-Mañas L
J Diabetes Complications; 2000; 14(4):224-33. PubMed ID: 11004432
[TBL] [Abstract][Full Text] [Related]
24. Vascular action of the hypoglycaemic agent gliclazide in diabetic rabbits.
Pagano PJ; Griswold MC; Ravel D; Cohen RA
Diabetologia; 1998 Jan; 41(1):9-15. PubMed ID: 9498623
[TBL] [Abstract][Full Text] [Related]
25. [Hypoglycemic effect of chitosan-microcapsulated insulin on the blood glucose level of streptozotocin-diabetic Wistar rats].
Huang H; Tian H; Li X; Zhao G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Sep; 18(3):425-7, 460. PubMed ID: 11605507
[TBL] [Abstract][Full Text] [Related]
26. The in vivo interaction between gliclazide and glibenclamide and insulin on glucose disposal in the rat.
Tanira MO; Furman BL
Pharmacol Res; 1999 May; 39(5):349-56. PubMed ID: 10328992
[TBL] [Abstract][Full Text] [Related]
27. Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats.
Attia HN; Al-Rasheed NM; Al-Rasheed NM; Maklad YA; Ahmed AA; Kenawy SA
Behav Pharmacol; 2012 Apr; 23(2):153-61. PubMed ID: 22411174
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal residual strain and stress-strain relationship in rat small intestine.
Dou Y; Fan Y; Zhao J; Gregersen H
Biomed Eng Online; 2006 Jun; 5():37. PubMed ID: 16759387
[TBL] [Abstract][Full Text] [Related]
29. Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats.
Dachicourt N; Bailbé D; Gangnerau MN; Serradas P; Ravel D; Portha B
Eur J Pharmacol; 1998 Nov; 361(2-3):243-51. PubMed ID: 9865514
[TBL] [Abstract][Full Text] [Related]
30. Morphometric and biomechanical remodeling of the small intestine during aging in rats.
Zhao J; Gregersen H
J Biomech; 2015 Dec; 48(16):4271-8. PubMed ID: 26596717
[TBL] [Abstract][Full Text] [Related]
31. Acute gliclazide administration enhances glucose and ketone body utilization in the perfused hind limb of normal and streptozotocin-diabetic rats.
Okuda Y; Kobayashi K; Ohmori H; Sone H; Suzuki M; Ma J; Nakajima T; Yamada N; Yamashita K
Life Sci; 2002 Jun; 71(6):647-54. PubMed ID: 12072153
[TBL] [Abstract][Full Text] [Related]
32. [Effects of gliclazide on blood rheology of diabetes Wistar rat].
Jiang C; Li Y
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):313-4. PubMed ID: 12600119
[TBL] [Abstract][Full Text] [Related]
33. [The effects of insulin and gliclazide therapy on endoplasmic reticulum stress and insulin sensitivity in liver of type 2 diabetic rats].
Sun WP; Bi Y; Liang H; Cai MY; Chen X; Zhu YH; Liao LZ; Weng JP
Zhonghua Nei Ke Za Zhi; 2012 Aug; 51(8):638-41. PubMed ID: 23158865
[TBL] [Abstract][Full Text] [Related]
34. Morphometric and biomechanical remodelling in the intestine after small bowel resection in the rat.
Dou Y; Lu X; Zhao J; Gregersen H
Neurogastroenterol Motil; 2002 Feb; 14(1):43-53. PubMed ID: 11874553
[TBL] [Abstract][Full Text] [Related]
35. Intestinal remodelling in mink fed with reduced protein content.
Chen P; Zhao J; Nielsen VH; Clausen T; Gregersen H
J Biomech; 2009 Mar; 42(4):443-8. PubMed ID: 19159886
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal transition and anti-diabetic effect of Isabgol husk microparticles containing gliclazide.
Sharma VK; Mazumder B
Int J Biol Macromol; 2014 May; 66():15-25. PubMed ID: 24530641
[TBL] [Abstract][Full Text] [Related]
37. Gliclazide attenuates the intracellular Ca2+ changes induced in vitro by ischemia in the retinal slices of rats with streptozotocin-induced diabetes.
Kinukawa J; Shimura M; Harata N; Tamai M
Curr Eye Res; 2005 Sep; 30(9):789-98. PubMed ID: 16146925
[TBL] [Abstract][Full Text] [Related]
38. Immediate insulin treatment prevents gut motility alterations and loss of nitrergic neurons in the ileum and colon of rats with streptozotocin-induced diabetes.
Izbéki F; Wittman T; Rosztóczy A; Linke N; Bódi N; Fekete E; Bagyánszki M
Diabetes Res Clin Pract; 2008 May; 80(2):192-8. PubMed ID: 18242757
[TBL] [Abstract][Full Text] [Related]
39. Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats.
Al-Salami H; Butt G; Tucker I; Golocorbin-Kon S; Mikov M
Eur J Drug Metab Pharmacokinet; 2012 Jun; 37(2):99-108. PubMed ID: 21874525
[TBL] [Abstract][Full Text] [Related]
40. Effective and selective prevention of retinal leukostasis in streptozotocin-induced diabetic rats using gliclazide.
Kinoshita N; Kakehashi A; Inoda S; Itou Y; Kuroki M; Yasu T; Kawakami M; Kanazawa Y
Diabetologia; 2002 May; 45(5):735-9. PubMed ID: 12107755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
